Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wearable tech aims to boost sleep apnea treatment adherence

NCT ID NCT06039865

Disease control Sponsor: VA Greater Los Angeles Healthcare System Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This trial tests whether a program using a consumer wearable device—which tracks oxygen levels during sleep—along with personalized weekly reports can help adults with obstructive sleep apnea use their positive airway pressure (PAP) therapy more consistently. Participants who are not currently adhering to their PAP therapy will either receive the wearable program immediately or after a waiting period, during which they receive usual care. The study compares changes in PAP usage between the two groups over about five weeks to see if the wearable-based approach improves adherence.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A consumer wearable device that measures oxygen levels during sleep, paired with customized weekly reports
What this could lead to
If effective, this wearable-based program could offer a simple, low-cost way to help people with sleep apnea stick to their PAP therapy, potentially improving sleep and overall health.
What could go wrong
The trial is small (50 participants) and early, so results may not apply to everyone. The wearable device may not be as accurate as medical-grade equipment, and the program's success depends on participants' willingness to use it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Oct 2023

Finished

Jan 2025

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Prescribed PAP therapy from the sleep center for \> 1 week * Have an active profile in our Center's ResMed AirView or Respironics Care Orchestrator accounts for \> 1 week * Non-adherent with PAP therapy * Willing to continue using current PAP device for 28 days continuously * Have an electronic device compatible with the wearable app Exclusion Criteria: * Diagnosis of heart failure, chronic lung disease, dementia, active substance use disorder * Use home oxygen * Unstable medical or psychiatric illness * Planned non-use of PAP therapy (e.g., waiting for replacement of recalled PAP device) * Planned surgery or hospitalization during study period * Planned extensive travel during study period * History of repeated non-attendance at clinic visits

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obstructive sleep apnea are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome sleep apnea syndrome Treatment Adherence and Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obstructive sleep apnea

Contacts and locations

Locations

  • VA Greater Los Angeles Healthcare System

    North Hills, California, 91343, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.